Otolaryngology Doctors in Berkeley Heights, NJ Accepting Medicare

9 Otolaryngology doctors found. Showing 1 - 9

Jed A. Kwartler, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1 Diamond Hill Rd, Summit Medical Group, Berkeley Heights, NJ 07922 Phone: 908-273-4300    Fax: 908-277-8662

Dr. David Harris Burstein, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1 Diamond Hill Rd, Berkeley Heights, NJ 07922 Phone: 908-273-4300

Dr. Alexander R Gnoy, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1 Diamond Hill Rd, Summit Medical Group, Berkeley Heights, NJ 07922 Phone: 908-273-4300    Fax: 908-277-8662

Robin T Bigelow, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 1 Diamond Hill Rd, Berkeley Heights, NJ 07922 Phone: 908-277-8681    Fax: 908-277-8662

Dr. Lowell Evan Gurey, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1 Diamond Hill Rd, Otolaryngology Department, Berkeley Heights, NJ 07922 Phone: 908-273-4300

Dr. David M Cooper, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1 Diamond Hill Rd, Summit Medical Group, Berkeley Heights, NJ 07922 Phone: 908-273-4300    Fax: 908-277-8662

Kaashif Eazazuddin, Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1 Diamond Hill Rd, Berkeley Heights, NJ 07922 Phone: 908-273-4300

Avrim R. Eden, M.D. Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 1 Diamond Hill Rd, Summit Medical Group, Berkeley Heights, NJ 07922 Phone: 908-273-4300    Fax: 908-277-8662

Dr. Jeffrey D Lebenger, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1 Diamond Hill Rd, Summit Medical Group, Berkeley Heights, NJ 07922 Phone: 908-273-4300    Fax: 908-277-8662

News Archive

Data from MAP Pharmaceuticals' LEVADEX clinical studies to be presented at AHS meeting

MAP Pharmaceuticals, Inc. today announced that the Company will present data on LEVADEX (formerly MAP0004), an orally inhaled investigational drug for the acute treatment of migraine, at the 54th Annual Scientific Meeting of the American Headache Society (AHS) in Los Angeles, CA, June 21-24, 2012.

First JLABS Incubator outside of the United States

The Ontario Government, University of Toronto, and MaRS Discovery District (MaRS) today announced a collaboration with Janssen Inc. to launch the successful Johnson & Johnson Innovation, JLABS incubator model in Toronto. The new facility, called JLABS @ Toronto, will open in spring of 2016 at MaRS Discovery District and will support start-ups with lab space, programs, and potential investment partners as they work to build important, successful early-stage companies.

Scripps physician first to treat heart attack patients with supersaturated oxygen therapy

A physician at Scripps Health's Prebys Cardiovascular Institute has become the first in the Western United States to treat heart attack patients with a new supersaturated oxygen (SSO2) system in an attempt to reduce permanent damage to their heart muscle.

Promising results from KAI-4169 program for CKD-MBD presented at ENDO 2011

KAI Pharmaceuticals, Inc., a privately held drug discovery and development company, today announced clinical and preclinical data from its lead program, KAI-4169, at the Endocrine Society's 93rd Annual Meeting (ENDO 2011) taking place in Boston, June 4-7, 2011. KAI-4169 is a novel pharmaceutical agent being developed for the treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD).

Read more Medical News

› Verified 8 days ago